DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
  • Stocks
  • /
  • Healthcare
Updated 1d ago
2U3 logo

Alcon Inc.XTRA:2U3 Stock Report

Market Cap €28.7b
Updated 1d ago
Share Price
n/a
1Y-12.1%
7D-5.7%
1D-0.1%
Portfolio Value
​
View

Alcon Inc.

XTRA:2U3 Stock Report

Market Cap: €28.7b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Alcon (2U3) Stock Overview

Researches, develops, manufactures, distributes, and sells eye care products worldwide. More details

2U3 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance1/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 47.6% below our estimate of its fair value

Earnings are forecast to grow 25.74% per year

Analysts in good agreement that stock price will rise by 32.4%

Risk Analysis

Large one-off items impacting financial results

Profit margins (5.9%) are lower than last year (10.7%)


2U3 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW436,082 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
436,082 investors already sharing narratives
€
Current Price
€59.3410.1% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-779m14b2016201920222025202620282031Revenue US$14.4bEarnings US$851.8m
Advanced
View all narratives

Alcon Inc. Competitors

Paul Hartmann

Symbol: DB:PHH2
Market cap: €706.8m

Siemens Healthineers

Symbol: XTRA:SHL
Market cap: €43.2b

Fresenius SE KGaA

Symbol: XTRA:FRE
Market cap: €24.5b

Fresenius Medical Care

Symbol: XTRA:FME
Market cap: €10.2b

Price History & Performance

Summary of share price highs, lows and changes for Alcon
Historical stock prices
Current Share PriceCHF 59.34
52 Week HighCHF 74.62
52 Week LowCHF 52.42
Beta0.70
1 Month Change-4.93%
3 Month Change3.85%
1 Year Change-12.09%
3 Year Changen/a
5 Year Changen/a
Change since IPO24.21%

Recent News & Updates

Recent updates

Shareholder Returns

2U3DE Medical EquipmentDE Market
7D-5.7%-2.2%-0.5%
1Y-12.1%-19.6%4.6%

Return vs Industry: 2U3 exceeded the German Medical Equipment industry which returned -17.1% over the past year.

Return vs Market: 2U3 underperformed the German Market which returned 5.5% over the past year.

Price Volatility

Is 2U3's price volatile compared to industry and market?
2U3 volatility
2U3 Average Weekly Movement3.5%
Medical Equipment Industry Average Movement5.3%
Market Average Movement5.0%
10% most volatile stocks in DE Market12.4%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 2U3 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 2U3's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194525,000David Endicottwww.alcon.com

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

Alcon Inc. Fundamentals Summary

How do Alcon's earnings and revenue compare to its market cap?
2U3 fundamental statistics
Market cap€28.67b
Earnings (TTM)€552.85m
Revenue (TTM)€9.34b
51.9x
P/E Ratio
3.1x
P/S Ratio

Is 2U3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2U3 income statement (TTM)
RevenueUS$10.86b
Cost of RevenueUS$4.65b
Gross ProfitUS$6.22b
Other ExpensesUS$5.57b
EarningsUS$643.00m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 11, 2026

Earnings per share (EPS)1.33
Gross Margin57.22%
Net Profit Margin5.92%
Debt/Equity Ratio21.9%

How did 2U3 perform over the long term?

See historical performance and comparison

Dividends

0.5%
Current Dividend Yield
27%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 12:43
End of Day Share Price 2026/09/09 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alcon Inc. is covered by 60 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
null nullBaird
Jeffrey JohnsonBaird

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide